ATLANTA, GA -- (MARKET WIRE) -- January 04, 2007 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, will be presenting a company overview and update at the 25th Annual JPMorgan Healthcare Conference on Wednesday, January 10, 2007, at 10:30 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco, Calif.
